How Hone Health Is Changing The Conversation Around Longevity
Saad Alam co-founded Hone Health to shift self-care from quick fixes to proactive longevity by focusing on biomarkers and hormone health. Earlier this year, the company raised $33 million in a Series A round
Self-care, for many, means green juices, digital detoxes and workout classes. But for Saad Alam, co-founder and CEO of Hone Health, that view ignores the science behind longevity.
“Self-care is about becoming the architect of your own biology,” Alam told Athletech News. “It’s tracking the systems that power your energy, cognition, hormones and resilience before something breaks.”
Hone Health was born from a personal loss: Alam watched a loved one deteriorate from a preventable illness, not because warning signs were absent, but because the system failed to catch them early enough. Around the same time, Alam experienced his own health concerns, low energy and mental fog. After countless doctor visits yielded no clear answers, one test revealed low testosterone levels, providing a turning point in his understanding of health.
Launched in 2020, Hone Health offers diagnostic-first preventive care with a focus on biomarkers and hormone health, aiming to help people identify risk factors long before symptoms arise.
Biomarkers — biological indicators like hormone levels, lipid panels and inflammation markers — can often feel abstract. Hone’s approach is to simplify the experience: patients get comprehensive testing, followed by a 45-minute physician consultation and customized treatment plan.
“Our role is to remove friction, eliminate gatekeeping, and give people a faster path to understanding what’s going on in their bodies,” Alam explained.
One area Hone focuses on is hormonal imbalance, an often-overlooked driver of fatigue and lack of motivation.
“Most people chalk these symptoms up to stress or aging,” Alam said. “But they’re often the result of measurable biological shifts that can be reversed.”
Other commonly neglected health factors include sleep quality, chronic inflammation, and visceral fat, each closely linked to long-term health outcomes but rarely prioritized in standard checkups.
With International Self-Care Day recently observed on July 24, Alam offered one concrete recommendation: get a biomarker test.
“One data point today can completely reframe how you think about your health and help you avoid a chronic condition five years from now,” he said.
Alam believes the future lies in a system that is diagnostic-first, physician-led, and AI-enhanced. With more than 400,000 patients tested and 65,000 treated, Hone Health is expanding this new approach to healthcare. The company closed a $33 million Series A funding round earlier this year, bringing its total funding to $39 million and fueling its expansion into proactive longevity care.
As part of its growth strategy, Hone also acquired in-home care platform ivee to broaden access to personalized health solutions.
“Healthcare is undergoing a generational reset,” Alam said. “Prevention isn’t abstract anymore — it’s specific, measurable, and increasingly within reach.”